September 24, 2020
Sun Pharma Japan said on September 23 that its anti-IL-23 antibody Ilumya (tildrakizumab) is now available in Japan for the treatment of plaque psoriasis inadequately controlled with existing treatments. Ilumya is the first innovative product that the Indian drug maker...read more